Varicella zoster virus the ACIP recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. In 2006, the United States Food and Drug Administration approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to elicit an immune response in older adults whose immunity to VZV wanes with advancing age. A systematic review by the Cochrane Library shows that Zostavax reduces the incidence of shingles by almost 50%. Shingrix is a "V. zoster" vaccine developed by GlaxoSmithKline which was approved in the United States by the
Technical diving magazine was using the term "technical diving", as an analogy with the established term "technical (rock) climbing". In the US the Occupational Safety and Health Administration categorises diving which is not occupational as "recreational diving" for purposes of exemption from regulation. This is also the case in some other countries, including South Africa. There is some professional disagreement as to what exactly technical diving encompasses. Nitrox diving and rebreather diving were originally considered technical, but this is no longer universally the case as several certification agencies now offer Recreational Nitrox and recreational rebreather training and certification. Some training agencies classify